Molecular Profile Study of Extracellular Vesicles for the Identification of Useful Small “Hit” in Cancer Diagnosis
Source abstract
Abstract
Tumor-secreted extracellular vesicles (EVs) are the main mediators of cell-cell communication, permitting cells to exchange proteins, lipids, and metabolites in varying physiological and pathological conditions. They contain signature tumor-derived molecules that reflect the intracellular status of their cell of origin. Recent studies have shown that tumor cell-derived EVs can aid in cancer metastasis through the modulation of the tumor microenvironment, suppression of the immune system, pre-metastatic niche formation, and subsequent metastasis. EVs can easily be isolated from a variety of biological fluids, and their content makes them useful biomarkers for the diagnosis, prognosis, monitorization of cancer progression, and response to treatment. This review aims to explore the biomarkers of cancer cell-derived EVs obtained from liquid biopsies, in order to understand cancer progression and metastatic evolution for early diagnosis and precision therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy
Área de Parasitología, Departamento Farmacia y Tecnología Farmacéutica y Parasitología, F. Farmacia, Universitat de València, 46100 Burjassot, Spain
Joint Unit of Endocrinology, Nutrition and Clinical Dietetics, Instituto de Investigación Sanitaria-La Fe, 46026 Valencia, Spain
Funding
Generalitat Valenciana · Agencia Estatal de Investigacion, Spain · Agencia Estatal de Investigación
References (100+)
Show source-provided references
1. Tumor progression
2. Universal Patterns of Selection in Cancer and Somatic Tissues10.1016/j.cell.2017.09.042 ↗
3. Detection of single cell heterogeneity in cancer10.1016/j.semcdb.2016.09.003 ↗
4. Proteomics study of serum exosomes from papillary thyroid cancer patients10.1530/ERC-17-0547 ↗
5. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes10.7150/thno.19890 ↗
6. Salivary Exosomes: Emerging Roles in Systemic Disease10.7150/ijbs.25018 ↗
7. Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
8. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients10.1016/j.neures.2019.10.010 ↗
9. Biological properties of extracellular vesicles and their physiological functions10.3402/jev.v4.27066 ↗
10. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles10.1146/annurev-cellbio-101512-122326 ↗
11. Ectosomes and exosomes: Shedding the confusion between extracellular vesicles10.1016/j.tcb.2015.01.004 ↗
12. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes10.1073/pnas.1521230113 ↗
13. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines10.1080/20013078.2018.1535750 ↗
14. Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside10.1016/j.bbcan.2017.10.001 ↗
15. Extracellular vesicles: Their role in cancer biology and epithelial-mesenchymal transition10.1042/BCJ20160006 ↗
16. Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules10.1186/s13046-018-0915-z ↗
17. Biology and clinical relevance of EpCAM10.15698/cst2019.06.188 ↗
18. Xavier, C.P.R., Caires, H.R., Barbosa, M.A.G., Bergantim, R., Guimarães, J.E., and Vasconcelos, M.H. (2020). The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance. Cells, 9.10.3390/cells9051141 ↗
19. Extracellular Vesicles Are Key Regulators of Tumor Neovasculature10.3389/fcell.2020.611039 ↗
20. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases10.1016/j.biopha.2018.12.022 ↗
21. Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia10.1089/ten.tea.2016.0508 ↗
22. EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling10.1172/jci.insight.132447 ↗
23. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface10.1038/s41467-018-04695-7 ↗
24. A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis10.1038/ncomms14450 ↗
25. Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling10.1016/j.matbio.2018.05.002 ↗
26. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway10.1038/s41419-018-0534-9 ↗
27. Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases10.1038/s41419-018-0425-0 ↗
28. Tumour exosome integrins determine organotropic metastasis10.1038/nature15756 ↗
29. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis10.1038/ncomms15016 ↗
30. Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizontal transfer of neoplastic traits, and the emergence of therapeutic resistance10.1016/j.semcancer.2021.01.007 ↗
31. Jella, K.K., Nasti, T.H., Li, Z., Malla, S.R., Buchwald, Z.S., and Khan, M.K. (2018). Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy. Vaccines, 6.10.3390/vaccines6040069 ↗
32. Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling10.1074/jbc.M113.512806 ↗
33. Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis10.1158/1541-7786.MCR-16-0163 ↗
34. Exosomal TGF-β1 is correlated with lymphatic metastasis of gastric cancers
35. Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells10.3892/ol.2015.3841 ↗
36. Mittal, S., Gupta, P., Chaluvally-Raghavan, P., and Pradeep, S. (2020). Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression. Cancers, 12.10.3390/cancers12123563 ↗
37. Enomoto, Y., Li, P., Jenkins, L.M., Anastasakis, D., Lyons, G.C., Hafner, M., and Leonard, W.J. (2021). Cytokine-enhanced cytolytic activity of exosomes from NK Cells. Cancer Gene.10.1038/s41417-021-00352-2 ↗
38. Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy10.2147/IJN.S313912 ↗
39. The clinical role of the TME in solid cancer10.1038/s41416-018-0327-z ↗
40. Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome10.1002/pmic.201800148 ↗
41. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts10.1038/s41388-019-1014-0 ↗
42. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: An exploratory analysis10.1007/s10549-017-4656-z ↗
43. Mesenchymal Stem Cells in the Tumor Microenvironment10.1007/978-3-030-37184-5_3 ↗
44. Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis10.1084/jem.20190158 ↗
45. Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells10.1038/s41556-019-0299-0 ↗
46. Lucchetti, D., Ricciardi Tenore, C., Colella, F., and Sgambato, A. (2020). Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity. Cancers, 12.10.3390/cancers12010171 ↗
47. The future of Extracellular Vesicles as Theranostics-an ISEV meeting report10.1080/20013078.2020.1809766 ↗
48. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics10.1016/j.mam.2019.10.005 ↗
49. Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group10.1089/bio.2016.0018 ↗
50. Urine Task Force of the International Society for Extracellular Vesicles10.1002/jev2.12093 ↗
51. The Use of Selected Urine Chemistries in the Diagnosis of Kidney Disorders10.2215/CJN.10330818 ↗
52. Urinary extracellular vesicles: Origin, role as intercellular messengers and biomarkers; efficient sorting and potential treatment options10.1111/apha.13346 ↗
53. Urinary extracellular vesicles. A promising shortcut to novel biomarker discoveries10.1007/s00441-017-2621-0 ↗
54. Facile preparation of salivary extracellular vesicles for cancer proteomics10.1038/srep24669 ↗
55. Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva10.1016/bs.enz.2017.08.002 ↗
56. Proteomic analysis of two types of exosomes in human whole saliva10.1248/bpb.34.13 ↗
57. Vijay, A., Inui, T., Dodds, M., Proctor, G., and Carpenter, G. (2015). Factors That Influence the Extensional Rheological Property of Saliva. PLoS ONE, 10.10.1371/journal.pone.0135792 ↗
58. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease10.1007/s00401-018-1807-1 ↗
59. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors10.2147/OTT.S229562 ↗
60. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research10.3402/jev.v2i0.20360 ↗
61. The biology and function of exosomes in cancer10.1172/JCI81135 ↗
62. Simeone, P., Bologna, G., Lanuti, P., Pierdomenico, L., Guagnano, M.T., Pieragostino, D., Del Boccio, P., Vergara, D., Marchisio, M., and Miscia, S. (2020). Extracellular Vesicles as Signaling Mediators and Disease Biomarkers across Biological Barriers. Int. J. Mol. Sci., 21.10.3390/ijms21072514 ↗
63. Isolation of Extracellular Vesicles: General Methodologies and Latest Trends10.1155/2018/8545347 ↗
64. Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin10.1002/jev2.12128 ↗
65. Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol10.1038/srep17319 ↗
66. Extracellular vesicle isolation methods: Rising impact of size-exclusion chromatography10.1007/s00018-019-03071-y ↗
67. High-speed centrifugation induces aggregation of extracellular vesicles10.3402/jev.v4.29509 ↗
68. Different isolation approaches lead to diverse glycosylated extracellular vesicle populations10.1080/20013078.2019.1621131 ↗
69. Impact of isolation methods on the biophysical heterogeneity of single extracellular vesicles10.1038/s41598-020-70245-1 ↗
70. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum10.1038/s41598-020-57497-7 ↗
71. Isolation of urinary extracellular vesicles from Tamm- Horsfall protein-depleted urine and their application in the development of a lectin-exosome-binding assay10.2144/000114208 ↗
72. Gurunathan, S., Kang, M.H., Jeyaraj, M., Qasim, M., and Kim, J.H. (2019). Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. Cells, 8.10.3390/cells8040307 ↗
73. Exosomes Regulate the Transformation of Cancer Cells in Cancer Stem Cell Homeostasis10.1155/2018/4837370 ↗
74. Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion10.1038/s41598-018-27180-z ↗
75. Tan, C.F., Teo, H.S., Park, J.E., Dutta, B., Tse, S.W., Leow, M.K., Wahli, W., and Sze, S.K. (2020). Exploring Extracellular Vesicles Biogenesis in Hypothalamic Cells through a Heavy Isotope Pulse/Trace Proteomic Approach. Cells, 9.10.3390/cells9051320 ↗
76. Reina, M., and Espel, E. (2017). Role of LFA-1 and ICAM-1 in Cancer. Cancers, 9.10.20944/preprints201709.0146.v1 ↗
77. Transfer of extracellular vesicles during immune cell-cell interactions
78. Taha, E.A., Ono, K., and Eguchi, T. (2019). Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion. Int. J. Mol. Sci, 20.10.3390/ijms20184588 ↗
79. Mass-spectrometry-based molecular characterization of extracellular vesicles: Lipidomics and proteomics10.1021/pr501279t ↗
80. New Technologies for Analysis of Extracellular Vesicles10.1021/acs.chemrev.7b00534 ↗
81. EVpedia: An integrated database of high-throughput data for systemic analyses of extracellular vesicles10.3402/jev.v2i0.20384 ↗
82. ExoCarta: A Web-Based Compendium of Exosomal Cargo10.1016/j.jmb.2015.09.019 ↗
83. Vesiclepedia 2019: A compendium of RNA, proteins, lipids and metabolites in extracellular vesicles10.1093/nar/gky1029 ↗
84. Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage10.1016/j.ygyno.2011.04.035 ↗
85. Chantziou, A., Theodorakis, K., Polioudaki, H., de Bree, E., Kampa, M., Mavroudis, D., Castanas, E., and Theodoropoulos, P.A. (2021). Glycosylation Modulates Plasma Membrane Trafficking of CD24 in Breast Cancer Cells. Int. J. Mol. Sci, 22.10.3390/ijms22158165 ↗
86. Neoadjuvant Therapy for HER2-positive Breast Cancer10.2174/1574887112666170202165049 ↗
87. Fang, S., Tian, H., Li, X., Jin, D., Li, X., Kong, J., Yang, C., Yang, X., Lu, Y., and Luo, Y. (2017). Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS ONE, 12.10.1371/journal.pone.0175050 ↗
88. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers10.1038/s41598-020-70393-4 ↗
89. Proteomic analysis of exosome-like vesicles derived from breast cancer cells
90. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer10.1038/nature14581 ↗
91. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer10.1111/jcmm.12941 ↗
92. The potential of exosomes derived from colorectal cancer as a biomarker10.1016/j.cca.2018.09.007 ↗
93. Exploration of Potential Diagnostic Value of Protein Content in Serum Small Extracellular Vesicles for Early-Stage Epithelial Ovarian Carcinoma10.3389/fonc.2021.707658 ↗
94. Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis10.7150/jca.48531 ↗
95. Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry10.1021/acsnano.7b07782 ↗
96. Lee, C.H., Im, E.J., Moon, P.G., and Baek, M.C. (2018). Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. BMC Cancer, 18.10.1186/s12885-018-4952-y ↗
97. Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics10.1038/s41598-017-13092-x ↗
98. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma10.1002/hep.29291 ↗
99. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma10.1016/j.jhep.2017.02.024 ↗
100. Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma10.1002/pmic.201800159 ↗